Stock Market Live July 14, 2026: S&P 500 (SPY) Regaining Lost Ground on Inflation Report

Health and Healthcare

Biogen : BIIB

All Biogen Articles

607 Articles

Jon C. Ogg | Apr 11, 2011 at 2:01 PM EDT

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in…

Jon C. Ogg | Apr 11, 2011 at 8:46 AM EDT

Top Active Trader Alert Stocks (APOL, BCS, RBS, BIIB, LVLT, QUIK, TSTY, TYC)

We have many stocks on the move this morning. Our top pre-market movers for active traders and day traders alike…

Jon C. Ogg | Dec 31, 2010 at 8:32 AM EST

Top Analyst Upgrades & Downgrades (AMZN, APC, BIIB, CRIC, DFS, EJ)

The research calls are running light as many markets either close early or are on very low volume with skeleton…

Jon C. Ogg | Dec 7, 2010 at 8:08 AM EST

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Jon C. Ogg | Nov 6, 2010 at 12:07 PM EDT

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may…

Jon C. Ogg | Sep 22, 2010 at 8:39 AM EDT

Top Active Trader Stock Alerts (ADBE, BIIB, DB, MSFT, SEED, RIMM, VICL, VVUS)

Active traders and day traders have several key stocks to watch. We are tracking moves in Adobe Systems, Inc. (NASDAQ:…

Jon C. Ogg | Sep 9, 2010 at 1:57 PM EDT

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there…

Jon C. Ogg | Sep 9, 2010 at 8:24 AM EDT

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc.…

Jon C. Ogg | Aug 3, 2010 at 9:48 AM EDT

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a…

Jon C. Ogg | Jul 23, 2010 at 2:15 PM EDT

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the…

Jon C. Ogg | Jul 6, 2010 at 2:24 PM EDT

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and…

Jon C. Ogg | Jun 2, 2010 at 2:17 PM EDT

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and…

Jon C. Ogg | Apr 20, 2010 at 3:14 PM EDT

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Today’s version of the BioHealth Business Daily is again full of stocks on the move with news, and some not…

Jon C. Ogg | Apr 19, 2010 at 3:20 PM EDT

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Today’s version of the BioHealth Business Daily has many stocks moving on news, but oddly many of the real news…

Douglas A. McIntyre | Mar 23, 2010 at 7:47 AM EDT

Today’s Best Market Rumors (3/23/2010)

Updated thoughout the day. Carl Icahn will push for the sale of Biogen (BIIB) (Bloomberg) Buffett’s Berkshire Hathaway (BRK.B) may…

1 … 34 35 36 37 38 … 41

Biogen : BIIB

All Biogen Articles

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Top Active Trader Alert Stocks (APOL, BCS, RBS, BIIB, LVLT, QUIK, TSTY, TYC)

Top Analyst Upgrades & Downgrades (AMZN, APC, BIIB, CRIC, DFS, EJ)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Top Active Trader Stock Alerts (ADBE, BIIB, DB, MSFT, SEED, RIMM, VICL, VVUS)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Today’s Best Market Rumors (3/23/2010)

Stock Market Live July 14, 2026: S&P 500 (SPY) Regaining Lost Ground on Inflation Report

Live Nasdaq Composite: Tech Stocks Rise in Relief, Treasury Yields Fall as Cooler Inflation Gives Markets a Tailwind

‘Being Hated Is Not Good for Business’: Mark Cuban’s $130 Billion Warning for AI Companies

Shopify’s $120 Billion Revival Is Catching Shorts Off Guard

Google Vs. Nvidia: The Hidden Silicon Advantage That Could Let Google Dethrone Nvidia

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.

Coinbase Bet On a $22 Billion Prediction Market Business Based on ‘Truth Seeking.’ Its AI Just Got Caught in an Obvious Lie.

SPYI vs. JEPI: Which Monthly ‘Paycheck’ ETF Actually Wins When the Market Gets Ugly?

Biogen : BIIB

All Biogen Articles

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Top Active Trader Alert Stocks (APOL, BCS, RBS, BIIB, LVLT, QUIK, TSTY, TYC)

Top Analyst Upgrades & Downgrades (AMZN, APC, BIIB, CRIC, DFS, EJ)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Top Active Trader Stock Alerts (ADBE, BIIB, DB, MSFT, SEED, RIMM, VICL, VVUS)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Today’s Best Market Rumors (3/23/2010)

Stock Market Live July 14, 2026: S&P 500 (SPY) Regaining Lost Ground on Inflation Report

Live Nasdaq Composite: Tech Stocks Rise in Relief, Treasury Yields Fall as Cooler Inflation Gives Markets a Tailwind

‘Being Hated Is Not Good for Business’: Mark Cuban’s $130 Billion Warning for AI Companies

Shopify’s $120 Billion Revival Is Catching Shorts Off Guard

Google Vs. Nvidia: The Hidden Silicon Advantage That Could Let Google Dethrone Nvidia

Featured Reads

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.